Join Us | Booth 2750
This year, Entegris is showcasing a new solution at PharmSci 360: the Mini DLS system. This online technology is a potential revolution for particle characterization. Condensing hours of analytics into minutes, the Mini DLS system can provide moment-to-moment feedback on operations such as milling, microfluidization, and homogenization.
Visit us to learn how you can add real-time monitoring to pharmaceutical production, improving quality controls and reducing time to market for your nanoparticle-based processes.
Events Related Content
Nanotechnology has been referred to as potentially being the next technical revolution that could change the modern world. We are well suited with analytical solutions that will help you prepare proper nanoparticle samples that generate the most accurate and repeatable results.
Our Particle Characterization solutions enable customers to perform particle size analysis both in the laboratory and online, in real time, directly in 0the fluid stream process. In advanced-node CMP applications, automating the monitoring process can help prevent costly yield excursions.
Companies manufacturing parenteral drugs and ophthalmic solutions need to test for subvisible particulates using a liquid particle counter. Parenteral drugs must be tested according to USP <788> or <787> for therapeutic proteins. Choosing the best instrument for these tests involves matching the measurement requirements to system capabilities.